-
2
-
-
15644380122
-
Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-α therapy
-
Marcellin P, Boyer N, Gervais A, Martinot M, Pouteau M, Castelnau C, et al. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-α therapy. Ann Intern Med. 1997;127:875-81.
-
(1997)
Ann Intern Med.
, vol.127
, pp. 875-881
-
-
Marcellin, P.1
Boyer, N.2
Gervais, A.3
Martinot, M.4
Pouteau, M.5
Castelnau, C.6
-
3
-
-
84984533465
-
Long-term efficacy of ribavirin plus interferon α in the treatment of chronic hepatitis C
-
Lai MY, Kao JH, Yang PM, Wang JT, Chen PJ, Chan KW, et al. Long-term efficacy of ribavirin plus interferon α in the treatment of chronic hepatitis C. Gastroenterology. 1996;11:1307-12.
-
(1996)
Gastroenterology
, vol.11
, pp. 1307-1312
-
-
Lai, M.Y.1
Kao, J.H.2
Yang, P.M.3
Wang, J.T.4
Chen, P.J.5
Chan, K.W.6
-
4
-
-
0032501714
-
Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group
-
Reichard O, Norkrans G, Fryden A, Braconier JH, Sonnerbörg A, Weiland O. Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group. Lancet. 1998;351:83-7.
-
(1998)
Lancet
, vol.351
, pp. 83-87
-
-
Reichard, O.1
Norkrans, G.2
Fryden, A.3
Braconier, J.H.4
Sonnerbörg, A.5
Weiland, O.6
-
5
-
-
0009528429
-
Retreatment of relapse after interferon therapy for chronic hepatitis C: An international randomized controlled trial of interferon plus ribavirin vs interferon alone
-
Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon S, Trepo C, et al. Retreatment of relapse after interferon therapy for chronic hepatitis C: an international randomized controlled trial of interferon plus ribavirin vs interferon alone [Abstract], Hepatology. 1997;26:249A.
-
(1997)
Hepatology
, vol.26
-
-
Davis, G.L.1
Esteban-Mur, R.2
Rustgi, V.3
Hoefs, J.4
Gordon, S.5
Trepo, C.6
-
6
-
-
0031945834
-
Re-treatment of chronic hepatitis C with consensus interferon
-
Heathcote EJ, Keeffe EB, Lee SS, Feinman SV, Tong MJ, Reddy KR, et al. Re-treatment of chronic hepatitis C with consensus interferon. Hepatology. 1998;27:1136-43.
-
(1998)
Hepatology
, vol.27
, pp. 1136-1143
-
-
Heathcote, E.J.1
Keeffe, E.B.2
Lee, S.S.3
Feinman, S.V.4
Tong, M.J.5
Reddy, K.R.6
-
7
-
-
0030886964
-
National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C
-
National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C. Hepatology. 1997;26(Suppl 1):2S-10S.
-
(1997)
Hepatology
, vol.26
, Issue.1 SUPPL.
-
-
-
8
-
-
0030832591
-
Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C
-
Gavier B, Martinez-González MA, Riezu-Boj JI, Lasarte JJ, Garcia N, Civeira MP, et al. Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C. Gastroenterology. 1997;113:1647-53.
-
(1997)
Gastroenterology
, vol.113
, pp. 1647-1653
-
-
Gavier, B.1
Martinez-González, M.A.2
Riezu-Boj, J.I.3
Lasarte, J.J.4
Garcia, N.5
Civeira, M.P.6
-
9
-
-
0030720484
-
Estimates of the cost-effectiveness of a single course of interferon-α2b in patients with histologically mild chronic hepatitis C
-
Bennett WG, Inoue Y, Beck JR, Wong JB, Pauker SG, Davis GL. Estimates of the cost-effectiveness of a single course of interferon-α2b in patients with histologically mild chronic hepatitis C. Ann Intern Med. 1997;127: 855-65.
-
(1997)
Ann Intern Med.
, vol.127
, pp. 855-865
-
-
Bennett, W.G.1
Inoue, Y.2
Beck, J.R.3
Wong, J.B.4
Pauker, S.G.5
Davis, G.L.6
-
10
-
-
0031573119
-
Interferon-α for chronic hepatitis C: Reducing the uncertainties
-
Koff RS. Interferon-α for chronic hepatitis C: reducing the uncertainties [Editorial]. Ann Intern Med. 1997;127:918-20.
-
(1997)
Ann Intern Med.
, vol.127
, pp. 918-920
-
-
Koff, R.S.1
-
11
-
-
0014748535
-
Asymptomatic chronic hepatitis. Correlation between isolated serum transaminase abnormality and liver biopsy
-
Levine RA, Ranek L. Asymptomatic chronic hepatitis. Correlation between isolated serum transaminase abnormality and liver biopsy. Gastroenterology. 1970;58:371-8.
-
(1970)
Gastroenterology
, vol.58
, pp. 371-378
-
-
Levine, R.A.1
Ranek, L.2
-
12
-
-
0029778988
-
An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group
-
Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24: 289-93.
-
(1996)
Hepatology
, vol.24
, pp. 289-293
-
-
Bedossa, P.1
Poynard, T.2
-
13
-
-
0030933395
-
Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups
-
Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997;349:825-32.
-
(1997)
Lancet
, vol.349
, pp. 825-832
-
-
Poynard, T.1
Bedossa, P.2
Opolon, P.3
-
14
-
-
15844431546
-
The long-term pathological evolution of chronic hepatitis C
-
Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, et al. The long-term pathological evolution of chronic hepatitis C. Hepatology. 1996;23:1334-40.
-
(1996)
Hepatology
, vol.23
, pp. 1334-1340
-
-
Yano, M.1
Kumada, H.2
Kage, M.3
Ikeda, K.4
Shimamatsu, K.5
Inoue, O.6
-
15
-
-
0030955348
-
Therapy of hepatitis C: Patients with normal aminotransferase levels
-
Marcellin P, Levy S, Erlinger S. Therapy of hepatitis C: patients with normal aminotransferase levels. Hepatology. 1997;26(3 Suppl 1):133S-6S.
-
(1997)
Hepatology
, vol.263
, Issue.1 SUPPL.
-
-
Marcellin, P.1
Levy, S.2
Erlinger, S.3
-
16
-
-
0030767251
-
Alfa interferon treatment of hepatitis C virus RNA-positive patients with normal or near-normal alanine aminotransferase levels
-
Silverman AL, Piquette DL, Filipiak CL, Neill JS, Bayati N, Gordan SC. Alfa interferon treatment of hepatitis C virus RNA-positive patients with normal or near-normal alanine aminotransferase levels. Am J Gastroenterol. 1997;92:1793-5.
-
(1997)
Am J Gastroenterol.
, vol.92
, pp. 1793-1795
-
-
Silverman, A.L.1
Piquette, D.L.2
Filipiak, C.L.3
Neill, J.S.4
Bayati, N.5
Gordan, S.C.6
-
17
-
-
0031952915
-
Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity
-
Mathurin P, Moussalli J, Cadranel JF, Thibault V, Charlotte F, Dumouchel P, et al. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity. Hepatology. 1998;27:868-72.
-
(1998)
Hepatology
, vol.27
, pp. 868-872
-
-
Mathurin, P.1
Moussalli, J.2
Cadranel, J.F.3
Thibault, V.4
Charlotte, F.5
Dumouchel, P.6
-
18
-
-
0030882650
-
Chronic hepatitis C virus infection with repeatedly normal aminotransferase levels: Disease or not disease?
-
Pawlotsky JM. Chronic hepatitis C virus infection with repeatedly normal aminotransferase levels: disease or not disease? [Editorial] Am J Gastroenterol. 1997;92:1775-7.
-
(1997)
Am J Gastroenterol.
, vol.92
, pp. 1775-1777
-
-
Pawlotsky, J.M.1
-
19
-
-
15644383207
-
Efficacy of consensus interferon (CIFN) against chronic HCV patients with high viral titer. The Consensus Interferon Clinical Study Group
-
Suzuki H, Iino S, Omata M, Kumada H, Hino K. Efficacy of consensus interferon (CIFN) against chronic HCV patients with high viral titer. The Consensus Interferon Clinical Study Group [Abstract]. Hepatology. 1997; 26:422A.
-
(1997)
Hepatology
, vol.26
-
-
Suzuki, H.1
Iino, S.2
Omata, M.3
Kumada, H.4
Hino, K.5
-
21
-
-
4244214492
-
Iron reduction therapy in chronic hepatitis C
-
DiBisceglie A, Bonkovsky H, Krawitt E, Grace N. Killenberg P, Hunt C, et al. Iron reduction therapy in chronic hepatitis C [Abstract]. Hepatology. 1997;26:214A.
-
(1997)
Hepatology
, vol.26
-
-
DiBisceglie, A.1
Bonkovsky, H.2
Krawitt, E.3
Grace, N.4
Killenberg, P.5
Hunt, C.6
-
22
-
-
0030716330
-
A pilot study of recombinant interleukin-2 for treatment of chronic hepatitis C
-
Pardo M, Castillo I, Oliva H, Fernández-Flores A, Bárcena R, de Peuter MA, et al. A pilot study of recombinant interleukin-2 for treatment of chronic hepatitis C. Hepatology. 1997;26:1318-21.
-
(1997)
Hepatology
, vol.26
, pp. 1318-1321
-
-
Pardo, M.1
Castillo, I.2
Oliva, H.3
Fernández-Flores, A.4
Bárcena, R.5
De Peuter, M.A.6
-
23
-
-
0030912338
-
The molecular virology of hepatitis C
-
Major ME, Feinstone SM. The molecular virology of hepatitis C. Hepatology. 1997;25:1527-38.
-
(1997)
Hepatology
, vol.25
, pp. 1527-1538
-
-
Major, M.E.1
Feinstone, S.M.2
-
24
-
-
0030852745
-
Gene therapy for chronic viral hepatitis: Ribozymes, antisense oligonucleotides, and dominant negative mutants
-
von Weizsäcker F, Wieland S, Köck J, Offensperger WB, Offensperger S, Moradpour D, et al. Gene therapy for chronic viral hepatitis: ribozymes, antisense oligonucleotides, and dominant negative mutants. Hepatology. 1997;26:251-5.
-
(1997)
Hepatology
, vol.26
, pp. 251-255
-
-
Von Weizsäcker, F.1
Wieland, S.2
Köck, J.3
Offensperger, W.B.4
Offensperger, S.5
Moradpour, D.6
-
25
-
-
0031802131
-
Targeted inhibition of hepatitis C virus-directed gene expression in human hepatoma cell lines
-
Wu CH, Wu GY. Targeted inhibition of hepatitis C virus-directed gene expression in human hepatoma cell lines. Gastroenterology. 1998;114:1304-12.
-
(1998)
Gastroenterology
, vol.114
, pp. 1304-1312
-
-
Wu, C.H.1
Wu, G.Y.2
-
26
-
-
15644366585
-
Long-term efficacy of interferon in chronic hepatitis C
-
Berg T, Kaul T, Heuft HG, Naumann U, Lobeck H, Hopf U. Long-term efficacy of interferon in chronic hepatitis C [Abstract]. Hepatology 1997;26: 423A.
-
(1997)
Hepatology
, vol.26
-
-
Berg, T.1
Kaul, T.2
Heuft, H.G.3
Naumann, U.4
Lobeck, H.5
Hopf, U.6
|